IPOs Education - Page 40 | TalkMarkets

Content

All Posts > Content under IPOs Education
625 to 640 of 1833 Posts
<<< 1 ... 38 39 40 41 42 ... 115 >>>
GoHealth Shares Drop 9% On Day One Trading After $913M IPO
Article By: Benzinga
Thursday, July 16, 2020 6:45 AM EDT
The shares of GoHealth, Inc. dipped more than 9% on the first day of trading at the Nasdaq Stock Market Wednesday.
In this article: GOCO Also: BAC, GS, MS
Read
Israeli Startup Deal Digest – June 2020
Article By: Shelly Hod Moyal
Thursday, July 16, 2020 5:04 AM EDT
This June we tracked 27 announced deals totaling approximately $560 Million, and 8 exits worth over $1.5 Billion.
Read
Shopify Rival BigCommerce Files For IPO
Article By: Benzinga
Tuesday, July 14, 2020 5:15 AM EDT
BigCommerce on Monday announced it has filed for an initial public offering with the United States Securities and Exchange Commission.
In this article: BCS, GS, KEY, MS, SFTBY, SHOP
Read
Multiplan To Go Public In A Merger Deal With SPAC Churchill Capital At $11B Valuation
Article By: Benzinga
Monday, July 13, 2020 4:36 AM EDT
Multiplan on Sunday announced the company had reached a merger deal with special purpose acquisition company (SPAC) Churchill Capital III Corp. which values the company at $11 billion.
In this article: CCXX Also: C, NKLA
Read
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Article By: Benzinga
Sunday, July 12, 2020 3:17 PM EDT
Biotech stocks advanced in the week ended July 10 amid mixed news emerging out of the sector. FDA approved a few drugs, including Endo International PLC's cellulite treatment, while Merck & Co. & Eisai Co.'s combo therapy was rejected by the FDA.
In this article: MRK, ESALY, NVAX, SGEN, ENDP, GRTS, MNK, VRCA, SAVA, UMRX, GSK, ABT, JNJ, ANGO
Read
Opening Day: Cancer 'Killer' Nkarta Soars After Coming Public
Article By: The Fly
Sunday, July 12, 2020 1:44 PM EDT
Nkarta, which is developing "natural killer-based cell therapies" to treat cancer saw its stock surge on its first day of public trading.
In this article: PSTX
Read
Week In Review: Ocumension Climbs To $2.5 Billion Market Cap After $184 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, July 11, 2020 12:05 PM EDT
Ocumension, a Shanghai ophthalmic pharma, completed a $184 million Hong Kong IPO and climbed 152% in its first trading session, giving the company a valuation of about $2.5 billion. The company has raised $200 million in venture capital.
In this article: ZLAB, TPTX, HBM
Read
Lemonade, Accolade Jump In Trading Debuts
Article By: The Fly
Sunday, July 5, 2020 2:08 PM EDT
Both Accolade and Lemonade opened higher on Thursday, July 2, with the former selling more shares than expected, and the latter pricing above its raised range.
In this article: DNB, ACCD, LMND Also: PSTX
Read
Week In Review: China Life Science Announces Deals Worth $1.3 Billion
Article By: ChinaBio® Today
Saturday, July 4, 2020 4:09 PM EDT
Boehringer Ingelheim launched its External Innovation Hub China in Shanghai to increase the company's China R&D partnerships.. The Hub has $508 million to spend on China clinical research, expansion of production sites and research partnerships.
In this article: BNR
Read
How To Pick The Next Billion-Dollar Company
Article By: Money Morning
Saturday, July 4, 2020 12:44 PM EDT
Here's the thing about being a thematic investor: There's a small chance you will be very rich, and close to a 100% chance you will lose all your capital. The strategy I prefer is an investment style called generalist investing.
In this article: GOOGL, UBER, DKNG
Read
Online Insurer Lemonade Raises $319M In IPO
Article By: Benzinga
Thursday, July 2, 2020 7:36 AM EDT
Lemonade Inc. raised $319 million in its initial public offering on Wednesday.
In this article: LMND Also: GS, MS, SFTBY
Read
8 Stock Catalysts For The Week Ahead
Article By: Benzinga
Sunday, June 28, 2020 6:02 PM EDT
The S&P 500 finished off a difficult week on a low note June 26, after another turbulent week on Wall Street. Here are eight potential catalysts for the week ahead that could move the markets.
In this article: FDX, M, DNB, F, GM, INO, ADNW, SPY Also: SPX
Read
Pending Clinical Readouts In Focus During A Short Holiday Week
Article By: Benzinga
Sunday, June 28, 2020 3:03 PM EDT
Biotech stocks went on a seesaw ride along with the broader markets in the week ending June 26. Yet, there were some encouraging developments on the COVID-19 vaccine development front. Vaccine companies are going all out.
In this article: SNY, TBIO, VXRT, ALXN, NVAX, RVNC, ITCI, ZYNE, OBSV, ITRM, NVS, CERC, RGNX, BNTX, INO, CDMO, CALT
Read
As The Fed Pumps,The Stock Market Is Increasingly The Only Game In Town
Article By: Mises Institute
Sunday, June 28, 2020 8:40 AM EDT
While the economic storm caused by COVID-19 has seemed to wane (temporarily?), the stock market can’t seem to go but one direction—up.
In this article: AND Also: , C, GOOG, NFLX, MSFT, AMZN, GOOGL
Read
Week In Review: VistaGen Out-Licenses China/Asia Rights For Novel Anxiety Drug To EverInsight In $177 Million Deal
Article By: ChinaBio® Today
Saturday, June 27, 2020 2:00 PM EDT
VistaGen of South San Francisco out-licensed China/Southeast Asia rights for a novel anxiety treatment to EverInsight Therapeutics, a China in-licensing company, in a $177 million agreement.
In this article: VTGN Also: AGEN, HCM, GTHX, SEQUX, GILD, MRK
Read
Kura Sushi (KRUS): Restaurant IPO W/ Playbook For Success
Article By: ValueWalk
Thursday, June 25, 2020 9:04 PM EDT
KRUS is a patent-protected, technology-first sushi restaurant. The company offers high-quality sushi at low prices thanks to robotic rice makers, automated dishwashers, and a conveyor-belt delivery system.
In this article: KRUS
Read
625 to 640 of 1833 Posts
<<< 1 ... 38 39 40 41 42 ... 115 >>>